Evoke Pharma Inc

EVOK

Get informed when a big investor buys or sells

Market Cap$18.95M

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Evoke Pharma Inc	-5.4	-	-155%	2.2	-

$1.28

Current Fair Value

88.3% downside

Overvalued by 88.3% based on the discounted cash flow analysis.

Share Statistics

Market cap	$18.95 Million
Enterprise Value	$7.48 Million
Dividend Yield	$- (-)
Earnings per Share	$-2.81
Beta	-0.14
Outstanding Shares	2,557,408

Return

Return on Equity	-155.44%
Return on Assets	-33.39%
Return on Invested Capital	-141.81%

Valuation & Multiples

P/E Ratio	-5.38
PEG	45.23
Price to Sales	2.2
Price to Book Ratio	11.0
Enterprise Value to Revenue	0.52
Enterprise Value to EBIT	-1.55
Enterprise Value to Net Income	-2
Total Debt to Enterprise	0.02
Debt to Equity	0.03

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

November 13, 2025

EPS Estimate

$-0.45

Average shareholder expectation

Revenue Estimate

$4.33 M

Average shareholder expectation

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership